Skip to main content
ARAY
NASDAQ Industrial Applications And Services

Accuray Restates Financials, Discloses Material Weaknesses in Internal Controls, Receives Adverse Auditor Opinion

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Negative
Importance info
9
Price
$0.578
Mkt Cap
$62.066M
52W Low
$0.5
52W High
$2.33
52W Position info
16% above low
Off High info
75% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

ARAY sits 16% above its 52-week low of $0.5.

Summary

Accuray Inc. filed an amended annual report to restate prior financial statements due to errors in remaining performance obligations and disclosed material weaknesses in internal controls, leading to an adverse auditor opinion.


Key Events · Corporate Governance and Compliance · ARAY

  • Financial Statement Restatement

    The company restated its consolidated financial statements for the fiscal year ended June 30, 2025, and interim periods (September 30, 2024, December 31, 2024, and March 31, 2025).

  • Errors in RPO Disclosure

    Errors were identified in the methodology for determining and disclosing remaining performance obligations (RPO), leading to a significant reduction in reported RPO balances (e.g., from $818.2 million to $60.9 million for June 30, 2025).

  • No Impact on Core Financials

    The identified errors did not impact the previously reported Balance Sheets, Statements of Operations and Comprehensive Loss, or Statements of Cash Flows.

  • Material Weaknesses in Internal Controls

    Management concluded that internal control over financial reporting (ICFR) and disclosure controls and procedures (DCP) were not effective as of June 30, 2025, due to material weaknesses related to footnote disclosure review and GAAP analysis.


Analysis · ARAY · Industrial Applications And Services

This amended annual report is highly significant as it formalizes the restatement of financial statements for fiscal year 2025 and several interim periods, following the company's prior announcement of non-reliance on those financials. While the restatement primarily corrects errors in the disclosure of remaining performance obligations (RPO) and does not impact the core financial statements (revenue, net income, cash flows), the underlying cause is critical. The company identified material weaknesses in its internal control over financial reporting and disclosure controls and procedures. This led to an adverse opinion from its auditor, Grant Thornton LLP, on the effectiveness of its internal controls. This breakdown in financial reporting integrity, especially for a company already facing Nasdaq delisting risk and recent operational losses, signals significant governance and compliance challenges. Investors should view this as a serious concern regarding the reliability of the company's financial reporting and its ability to manage complex accounting standards. The remediation plan for these weaknesses will be crucial to monitor.

At the time of this filing, ARAY was trading at $0.58 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $62.1M. The 52-week trading range was $0.50 to $2.33. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ARAY - Latest Insights

ARAY
Jun 04, 2026, 4:02 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.3655
Real-time Price: $0.2501 info
Change: -$0.1154 (-32%) info
Market Cap: $29.753M info
ARAY
May 22, 2026, 3:57 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
8
Price at Filing: $0.3077
Real-time Price: $0.2501 info
Change: -$0.0576 (-19%) info
Market Cap: $29.753M info
ARAY
May 06, 2026, 4:09 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.4105
Real-time Price: $0.2501 info
Change: -$0.1604 (-39%) info
Market Cap: $29.753M info
ARAY
May 06, 2026, 4:07 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.4724
Real-time Price: $0.2501 info
Change: -$0.2223 (-47%) info
Market Cap: $29.753M info
ARAY
Apr 28, 2026, 9:00 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.4455
Real-time Price: $0.2501 info
Change: -$0.1954 (-44%) info
Market Cap: $29.753M info